Cargando…

Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation

Mature retinal ganglion cells (RGCs) do not normally regenerate injured axons and undergo apoptosis after axotomy. Inflammatory stimulation (IS) in the eye mediates neuroprotection and induces axon regeneration into the injured optic nerve. Ciliary neurotrophic factor (CNTF) and leukemia inhibitory...

Descripción completa

Detalles Bibliográficos
Autores principales: Leibinger, M, Müller, A, Gobrecht, P, Diekmann, H, Andreadaki, A, Fischer, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641349/
https://www.ncbi.nlm.nih.gov/pubmed/23618907
http://dx.doi.org/10.1038/cddis.2013.126
_version_ 1782268007348699136
author Leibinger, M
Müller, A
Gobrecht, P
Diekmann, H
Andreadaki, A
Fischer, D
author_facet Leibinger, M
Müller, A
Gobrecht, P
Diekmann, H
Andreadaki, A
Fischer, D
author_sort Leibinger, M
collection PubMed
description Mature retinal ganglion cells (RGCs) do not normally regenerate injured axons and undergo apoptosis after axotomy. Inflammatory stimulation (IS) in the eye mediates neuroprotection and induces axon regeneration into the injured optic nerve. Ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF) have been identified as key mediators of these effects. Here, we investigated the role of interleukin-6 (IL-6), another member of the glycoprotein 130-activating cytokine family, as additonal contributing factor. Expression of IL-6 was markedly induced in the retina upon optic nerve injury and IS, and mature RGCs expressed the IL-6 receptor. Treatment of cultured RGCs with IL-6 or specific IL-6 receptor agonist, significantly increased neurite outgrowth janus kinase/signal transducers and activators of transcription-3 (JAK/STAT3) and phosphatidylinositide 3-kinase/protein kinase B (PI3K/Akt) dependently. Moreover, IL-6 reduced myelin, but not neurocan-mediated growth inhibition mammalian target of rapamycin (mTOR) dependently in cultured RGCs. In vivo, intravitreal application of IL-6 transformed RGCs into a regenerative state, enabling axon regeneration beyond the lesion site of the optic nerve. On the other hand, genetic ablation of IL-6 in mice significantly reduced IS-mediated myelin disinhibition and axon regeneration in the optic nerve. Therefore, IL-6 contributes to the beneficial effects of IS and its disinhibitory effect adds an important feature to the effects of so far identified IS-mediating factors. Consequently, application of IL-6 or activation of its receptor might provide suitable strategies for enhancing optic nerve regeneration.
format Online
Article
Text
id pubmed-3641349
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36413492013-05-02 Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation Leibinger, M Müller, A Gobrecht, P Diekmann, H Andreadaki, A Fischer, D Cell Death Dis Original Article Mature retinal ganglion cells (RGCs) do not normally regenerate injured axons and undergo apoptosis after axotomy. Inflammatory stimulation (IS) in the eye mediates neuroprotection and induces axon regeneration into the injured optic nerve. Ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF) have been identified as key mediators of these effects. Here, we investigated the role of interleukin-6 (IL-6), another member of the glycoprotein 130-activating cytokine family, as additonal contributing factor. Expression of IL-6 was markedly induced in the retina upon optic nerve injury and IS, and mature RGCs expressed the IL-6 receptor. Treatment of cultured RGCs with IL-6 or specific IL-6 receptor agonist, significantly increased neurite outgrowth janus kinase/signal transducers and activators of transcription-3 (JAK/STAT3) and phosphatidylinositide 3-kinase/protein kinase B (PI3K/Akt) dependently. Moreover, IL-6 reduced myelin, but not neurocan-mediated growth inhibition mammalian target of rapamycin (mTOR) dependently in cultured RGCs. In vivo, intravitreal application of IL-6 transformed RGCs into a regenerative state, enabling axon regeneration beyond the lesion site of the optic nerve. On the other hand, genetic ablation of IL-6 in mice significantly reduced IS-mediated myelin disinhibition and axon regeneration in the optic nerve. Therefore, IL-6 contributes to the beneficial effects of IS and its disinhibitory effect adds an important feature to the effects of so far identified IS-mediating factors. Consequently, application of IL-6 or activation of its receptor might provide suitable strategies for enhancing optic nerve regeneration. Nature Publishing Group 2013-04 2013-04-25 /pmc/articles/PMC3641349/ /pubmed/23618907 http://dx.doi.org/10.1038/cddis.2013.126 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Leibinger, M
Müller, A
Gobrecht, P
Diekmann, H
Andreadaki, A
Fischer, D
Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
title Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
title_full Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
title_fullStr Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
title_full_unstemmed Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
title_short Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
title_sort interleukin-6 contributes to cns axon regeneration upon inflammatory stimulation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641349/
https://www.ncbi.nlm.nih.gov/pubmed/23618907
http://dx.doi.org/10.1038/cddis.2013.126
work_keys_str_mv AT leibingerm interleukin6contributestocnsaxonregenerationuponinflammatorystimulation
AT mullera interleukin6contributestocnsaxonregenerationuponinflammatorystimulation
AT gobrechtp interleukin6contributestocnsaxonregenerationuponinflammatorystimulation
AT diekmannh interleukin6contributestocnsaxonregenerationuponinflammatorystimulation
AT andreadakia interleukin6contributestocnsaxonregenerationuponinflammatorystimulation
AT fischerd interleukin6contributestocnsaxonregenerationuponinflammatorystimulation